• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Another non-profit looks to develop pediatric medical devices

Another non-profit looks to develop pediatric medical devices

February 22, 2010 By MedCity News

By Mary Vanac

MedCity News logo

CLEVELAND, Ohio — Tim Moran remembers hearing his prematurely born daughter scream in pain when the only available, excessively large airway mask was strapped to her head.

Years later, Moran, a medical device inventor who has helped commercialize and raise money for others’ devices, started PediaWorks, a not-for-profit organization that will work with medical professionals to develop pediatric medical devices, spinning off for-profit companies to commercialize those devices.

“This is something that’s geared to the common good of pediatrics,” Moran said. “It’s a great mission that I’d like to see everybody in the medical device community get involved in.”

In this age of technological plenty, health care still needs pediatric medical devices in multiple specialties. Lacking devices made just for children, doctors modify adult devices, sometimes causing their tiny patients discomfort, pain or injury. Other times, the modified devices — most often used “off label” or for uses unapproved by regulators — fail to work properly. Some patients must wait for procedures or treatments until they have grown big enough to accept them.

Most for-profit corporations are unwilling to invest in developing pediatric devices because they see small market potential, insufficient insurance reimbursement, difficulties in getting clinical data for Food & Drug Administration approval and looming legal liabilities, said Steve Girouard, senior director of emerging technologies for Johnson & Johnson (NYSE:JNJ), who has also worked for Guidant Corp. and the Cleveland Clinic.

“It’s do-able,” Girouard said of PediaWorks. “The hardest part is getting the capitalistic forces, and the philanthropic and altruistic forces behind it. But I think there’s a path here.”

Moran formed PediaWorks late last year as a nonprofit organization so it could accept philanthropic money from big medical device makers and foundations. He plans to use the organization to gather ideas and develop devices, then create small, for-profit businesses to commercialize the products. The small businesses would have access to federal Small Business Innovation Research grants.

So far, though, the organization is short on cash — it’s raised just $30,000 through a grant from Cleveland’s Civic Innovation Lab, as well as support through the local trade group BioEnterprise. It’s relying on an extensive network of pediatric surgeons and specialists to supply the ideas, professionals at large device manufacturers who might allow their adult-sized products to be re-engineered for kids and engineering professionals to redesign the products or come up with new ones.

Moran is the only employee of PediaWorks, but Bob Johnson, leader of the medical devices team at BioEnterprise, and Dr. Fahd Khan, a senior neurosurgery resident at Case Western Reserve University and University Hospitals Case Medical Center, as well as a biomedical innovation fellow at the Case Department of Biomedical Engineering, also lend a hand.

Moran has tapped into the Congenital Cardiovascular Interventional Study Consortium, a group of international cardiologists who share information about pediatric products, procedures and outcomes. He’s also working with UH Rainbow Babies & Children’s Hospital in Cleveland, Cleveland Clinic Children’s Hospital and Lucile Packard Children’s Hospital at Stanford to identify unmet device needs. He works with the University of California, San Francisco and Stanford Research Institute to design, engineer and prototype the devices.

PediaWorks and its collaborators are working on four products:

  1. A series of cardiac catheters designed for the size and anatomy of the pediatric heart (CCISC and the Clinic Children’s Hospital);
  2. A simple device that would reduce the time it takes to remove a pediatric brain tumor to less than five minutes from 30 minutes, while also dramatically reducing brain trauma (UH Rainbow);
  3. A portable, low-cost way to ensure clinicians can place endotracheal tubes as quickly and safely as possible (Case biomedical engineering students);
  4. A method and device to verify central vein catheter placement without the need for X-rays (UH Rainbow).

The Center for Clinical Research and Technology at University Hospitals Case Medical Center is “very much behind the effort,” said Stephen Behm, the research center’s director of technology management. The center is providing access to UH clinicians and is working with PediaWorks to identify marketplace needs, Behm said.

In the future, the center expects to help PediaWorks design and conduct clinical trials and help commercialize its products, he said.

Moran is already talking with contract manufacturers who could make the devices.

“My goal for the organization is not to do any direct manufacturing,” he said, but to build a large enough product design portfolio and sales and marketing operation to make the organization and its spin-off companies sustainable.

Moran picked up the pediatric medical device thread more than a year ago. Previously, he founded, managed and raised a round of venture financing for CSF Therapeutics, a developer of devices to treat neurodegenerative diseases and a spin-off company from the Cleveland Clinic.

He also managed a financing round for Intelect Medical, another Clinic spin-off, and guided the market launch of Minimally Invasive Devices in Columbus. He’s also a co-inventor of PCT/US2008/012355 — a device for increasing blood flow to the brain.

PediaWorks is one of a few recent efforts to fill the need for children’s medical devices. Acknowledging the problem, the FDA in 2007 announced a $2 million annual grant program to stimulate the development and marketing of medical devices for children. Late last year, the regulator made its first grants to pediatric medical device consortia in Ann Arbor, Mich., Boston and San Francisco.

Mechanical engineer Brad Slaker started DesignWise Medical in Minneapolis around the same time to do similar things, using mostly volunteer medical and industrial professionals and college students.

In 2007, the Institute for Pediatric Innovation in Cambridge, Mass., formed as a nonprofit to focus on improving health care for children. The institute soon put together a consortium of pediatric hospitals, including UH Rainbow, to help with its mission.

Girouard said the nonprofit aspect of PediaWorks invites product collaboration by big device makers. “I think there is potentially a willingness among the big medical device companies to provide access to technology and freedom to operate if there’s not a competitive threat.”

Products designed for pediatric markets eventually could cross over to minimally invasive surgery markets for adults. “If you design for pediatrics, you are inherently making smaller devices,” which could be used in adult microsurgery, Moran said. There’s a “sizable market share there.”

Ohio already has some natural synergies to help grow a pediatrics medical device practice. Well-regarded hospitals including Akron Children’s Hospital Medical Center, Cincinnati Children’s Hospital Medical Center, Nationwide Children’s Hospital in Columbus, as well as Rainbow and Cleveland Clinic, all could contribute to such an effort. Plus, Cleveland has increasingly strong ties to OrthoPediatrics, an Indiana company that develops implants and therapies for children.

Girouard also said Cleveland is as likely a place as Minneapolis, a medical device powerhouse, to make devices for children or adults. “I think it may be a way that we can distinguish [Cleveland], grow a budding little device manufacturing core,” he said.

Chris Seper contributed to this report.

Filed Under: Business/Financial News, News Well, Pediatrics Tagged With: PediaWorks

In case you missed it

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Dyad Medical wins FDA clearance for cardiac imaging platform Echo:Prio
  • Outset Medical wins national VA contract
  • Inspire Medical Systems appoints former Zimmer Biomet exec as VP of investor relations
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Acutus Medical ticks up on revenue beat, missed EPS in Q2 results
  • ResMed expects steady growth over the next year
  • Ambu is letting go of 200 employees
  • Medtronic has Class I recall for low-shock risk in ICDs
  • Titan Medical to start manufacturing Enos systems later this year
  • ZimVie sales down more than 11% in Q2 as it streamlines after spinoff
  • Cardinal Health’s CFO to move up to corner office
  • Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform
  • Data supports use of Channel Medsystems Cerene cryotherapy
  • The 10 largest orthopedic device companies in the world
  • Nanopath raises $10M Series A for women’s health diagnostics
  • Avenda wins FDA IDE nod for AI-enabled prostate cancer therapy

RSS From Medical Design & Outsourcing

  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]
  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy